卵巢癌患者静脉与动脉血栓栓塞事件的发生率及危险因素:来自加拿大大型数据库的数据
这项回顾性队列研究基于不列颠哥伦比亚省癌症登记处1996至2017年的4491例上皮性卵巢癌患者,利用ICD编码从行政健康记录中识别血栓栓塞事件及危险因素。结果显示1.74%发生动脉血栓栓塞、9.44%发生静脉血栓栓塞,血栓栓塞事件与全因死亡率显著相关,脓毒症与静脉及动脉血栓栓塞均显著相关,动脉血栓栓塞前三位危险因素为外周血管病、开放性伤口和动脉瘤。作者认为动脉与静脉血栓栓塞的危险因素不一致,血栓事件不应合并分析,需差异化风险评估以改进预防策略并指导血栓预防。
要点
- 4491例上皮性卵巢癌患者中,动脉血栓栓塞发生率为1.74%,静脉血栓栓塞发生率为9.44%。
- 血栓栓塞事件的发生与全因死亡率存在显著关联。
- 脓毒症与静脉血栓栓塞及动脉血栓栓塞均显著相关。
核心结论
- 卵巢癌患者中预测血栓形成的危险因素在动脉血栓栓塞与静脉血栓栓塞之间不一致,因此血栓事件不应合并分析;需要差异化血栓风险评估以改进预防策略并指导这些患者的血栓预防。
研究设计与样本
- 回顾性队列研究,纳入不列颠哥伦比亚省癌症登记处1996年至2017年识别的4491例上皮性卵巢癌患者,通过ICD-9-CM和ICD-10-CM计费编码从按服务收费提供者就诊和医院数据的行政健康记录中识别血栓栓塞事件及危险因素,统计分析采用卡方检验和Fisher精确检验。
主要发现
- 4491例上皮性卵巢癌患者中,1.74%发生动脉血栓栓塞,9.44%发生静脉血栓栓塞。
- 血栓栓塞事件的发生与全因死亡率存在显著关联。
- 脓毒症与静脉血栓栓塞及动脉血栓栓塞均显著相关。
- 动脉血栓栓塞前三位危险因素包括外周血管病、开放性伤口和动脉瘤。
临床怎么用
- 作者认为血栓事件不应合并分析,需要差异化血栓风险评估以改进预防策略并指导这些患者的血栓预防。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the incidence of thromboembolic events (TEEs) in ovarian cancer patients and to identify risk factors that are significantly associated with the development of venous thromboembolism (VTE), arterial thromboembolism (ATE), or overall TEEs in this population. METHODS: This is a retrospective cohort study of 4491 patients with epithelial ovarian cancer identified in the British Columbia cancer registry between 1996 and 2017. The presence of TEEs and risk factors were identified in administrative health records from fee-for-service provider visits and hospital data using ICD-9-CM and ICD-10-CM billing codes. Statistical analysis was performed using Chi-squared test and Fischer's exact test. RESULTS: Of 4491 patients with epithelial ovarian cancer included in this study, 1.74% experienced ATE and (9.44%) experienced VTE. There was a significant association found between the occurrence of TEEs and all-cause mortality. Sepsis was significantly associated with both venous and arterial thromboembolism. The top three risk factors for arterial thromboembolism included peripheral vascular disease (PVD), open wound, and aneurysm. CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.
引用
- Penfound S, Lukey A, Hodgson J, et al. Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database. Gynecol Oncol. 2024. PMID: 38382168. doi:10.1016/j.ygyno.2024.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。